肺移植治疗中毒性表皮坏死松解症/Stevens-Johnson 综合征继发性闭塞性细支气管炎2例报告
收稿日期: 2024-09-30
录用日期: 2024-12-05
网络出版日期: 2025-06-27
基金资助
江苏省肺移植医学创新中心项目(CXZX2022001)
A report of two cases of bronchiolitis obliterans organizing pneumonia secondary to toxic epidermal necrolysis/Stevens-Johnson syndrome in lung transplantation treatment
Received date: 2024-09-30
Accepted date: 2024-12-05
Online published: 2025-06-27
目的 探讨肺移植治疗中毒性表皮坏死松解症/Stevens-Johnson 综合征继发性闭塞性细支气管炎的疗效。 方法 回顾性分析既往收治的2例中毒性表皮坏死松解症/Stevens-Johnson 综合征继发性闭塞性细支气管炎患儿的病历资料。结果 2例患者成功接受了肺移植手术且术后未见复发,其中1例术后16个月因感染死亡。文献检索出6例符合要求的患者资料,截至文献发表时均存活且未见疾病复发。结论 肺移植可能是治疗中毒性表皮坏死松解症/Stevens-Johnson 综合征继发性闭塞性细支气管炎的有效手段,可能具有良好的预后,围术期肺部感染的控制是关键。
关键词: 肺移植; 中毒性表皮坏死松解症; Stevens-Johnson 综合征; 闭塞性细支气管炎
梁佳龙 , 陈员 , 徐坚 , 叶书高 . 肺移植治疗中毒性表皮坏死松解症/Stevens-Johnson 综合征继发性闭塞性细支气管炎2例报告[J]. 临床儿科杂志, 2025 , 43(7) : 539 -542 . DOI: 10.12372/jcp.2025.24e1052
Objective To assess the efficacy of lung transplantation in managing bronchiolitis obliterans resulting from toxic epidermal necrolysis/Stevens-Johnson syndrome. Methods The medical records of 2 children with toxic epidermal necrolysis/Stevens-Johnson syndrome secondary bronchiolitis obliterans were retrospectively analyzed. Results Two patients successfully underwent lung transplantation and experienced no recurrence of their condition postoperatively. Tragically, one of these patients succumbed to an infection 16 months following the procedure. Additionally, we extracted data on six patients from the literature who fulfilled the criteria, and at the time of publication, all were reported to be alive and free from disease recurrence. Conclusions Lung transplantation emerges as a potentially effective therapeutic option for patients with toxic epidermal necrolysis/Stevens-Johnson syndrome who develop secondary bronchiolitis obliterans, suggesting a favorable prognosis. However, the crux of success lies in meticulous management of perioperative pulmonary infections.
| [1] | Seccombe EL, Ardern-Jones M, Walker W, et al. Bronchiolitis obliterans as a long-term sequela of Stevens-Johnson syndrome and toxic epidermal necrolysis in children[J]. Clin Exp Dermatol, 2019, 44(8): 897-902. |
| [2] | McPherson T, Exton LS, Biswas S, et al. British Association of Dermatologists' guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in children and young people, 2018[J]. Br J Dermatol, 2019, 181(1): 37-54. |
| [3] | Charlton OA, Harris V, Phan K, et al. Toxic epidermal necrolysis and Steven-Johnson syndrome: a comprehensive review[J]. Adv Wound Care (New Rochelle), 2020, 9(7): 426-439. |
| [4] | Lee HY, Walsh SA, Creamer D. Long-term complications of Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN): the spectrum of chronic problems in patients who survive an episode of SJS/TEN necessitates multidisciplinary follow-up[J]. Br J Dermatol, 2017, 177(4): 924-935. |
| [5] | Bastuji-Garin S, Rzany B, Stern RS, et al. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme[J]. Arch Dermatol, 1993, 129(1): 92-96. |
| [6] | Hsu DY, Brieva J, Silverberg NB, et al. Pediatric Stevens-Johnson syndrome and toxic epidermal necrolysis in the United States[J]. J Am Acad Dermatol, 2017, 76(5): 811-817. |
| [7] | Antoon JW, Goldman JL, Lee B, et al. Incidence, outcomes, and resource use in children with Stevens-Johnson syndrome and toxic epidermal necrolysis[J]. Pediatr Dermatol, 2018, 35(2): 182-187. |
| [8] | Kamada N, Kinoshita K, Togawa Y, et al. Chronic pulmonary complications associated with toxic epidermal necrolysis: report of a severe case with anti-Ro/SS-A and a review of the published work[J]. J Dermatol, 2006, 33(9): 616-622. |
| [9] | Xu N, Chen X, Wu S, et al. Chronic pulmonary complications associated with toxic epidermal necrolysis: a case report and literature review[J]. Exp Ther Med, 2018, 16(3):2027-2031. |
| [10] | Moonnumakal SP, Fan LL. Bronchiolitis obliterans in children[J]. Curr Opin Pediatr, 2008, 20(3): 272-278. |
| [11] | Park H, Ko YB, Kwon HS, et al. Bronchiolitis obliterans associated with Stevens-Johnson syndrome: a case report[J]. Yonsei Med J, 2015, 56(2): 578-581. |
| [12] | Tanou K, Xaidara A, Kaditis AG. Efficacy of pulse methylprednisolone in a pediatric case of postinfectious bronchiolitis obliterans[J]. Pediatr Pulmonol, 2015, 50(5): E13-E16. |
| [13] | Date H, Sano Y, Aoe M, et al. Living-donor lobar lung transplantation for bronchiolitis obliterans after Stevens-Johnson syndrome[J]. J Thorac Cardiovasc Surg, 2002, 123(2): 389-391. |
| [14] | Shoji T, Bando T, Fujinaga T, et al. Living-donor single-lobe lung transplant in a 6-year-old girl after 7-month mechanical ventilator support[J]. J Thorac Cardiovasc Surg, 2010, 139(5): e112-e113. |
| [15] | Zijtregtop EA, Pijnenburg MW, Rottier BL, et al. Bronchiolitis obliterans after Stevens-Johnson syndrome[J]. Ned Tijdschr Geneeskd, 2012, 156(19): A4387. |
| [16] | Matar M, Kessler R, Olland A, et al. End-stage respiratory failure secondary to bronchiolitis obliterans syndrome induced by toxic epidermal necrosis, also known as Lyell syndrome: a case report[J]. Transplant Proc, 2021, 53(4): 1371-1374. |
| [17] | YueB, Huang J, Jing L, et al. Bilateral lung transplantation for Castleman disease with end-stage bronchiolitis obliterans[J]. Clin Transplant, 2022, 36(1): e14496. |
| [18] | Soubani AO, Kingah P, Alshabani K, et al. Lung transplantation following hematopoietic stem cell transplantation: report of two cases and systematic review of literature[J]. Clin Transplant, 2014, 28(7):776-782. |
/
| 〈 |
|
〉 |